Myeloablative Temozolomide Enhances CD8+ T-Cell Responses to Vaccine and Is Required for Efficacy Against Brain Tumors in Mice
PLoS ONE - United States
doi 10.1371/journal.pone.0059082
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 18, 2013
Authors
Publisher
Public Library of Science (PLoS)